Genentech reported income of $42.2 million for...
- Share via
Genentech reported income of $42.2 million for 1987, contrasted with a loss of $353 million in 1986. Operating revenue totaled $230.5 million, up 72% from 1986. The South San Francisco biotechnology firm attributed the results to the fourth-quarter launch of Activase, which is used to dissolve blood clots in coronary arteries that cause heart attacks, and increasing sales of Protropin human growth hormone.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
